Clinical trials

7

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evacuation Time and Tourniquet Use as Risk Factors for PTSD in Combat-Related Amputation

This study aims to evaluate the relationship between evacuation time, tourniquet use, and the development of post-traumatic stress disorder (PTSD) in patients with combat-related amputations. In the context of modern warfare, prolonged evacuation times and extended tourniquet application may contribute not only to physical injury but also to psychological trauma. The study will prospectively follow patients over 18 months to identify key predictors of PTSD and to assess their interaction.

Participants needed: 300
Trial details
Age: 18-60Biological sex: AllType: ObservationalSponsor: Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)Updated: Apr 3, 2026Locations: 1Duration: 6 Months
Eligibility criteria

Ukrainian veterans with combat-related injury (post-February 2022) [+4]

Prior PTSD diagnosis before current injury [+3]

Status: Not yet recruiting

Negative Pressure Wound Therapy as a Predictor of Persistent Pain After War-Related Trauma

War-related trauma frequently causes complex soft tissue injuries that require repeated surgical treatment and advanced wound management techniques such as Negative Pressure Wound Therapy (NPWT). Although NPWT is widely used to promote wound healing and prepare wounds for reconstruction, its relationship with long-term pain outcomes remains unclear. This prospective cohort study aims to investigate whether the use of NPWT after war-related trauma is associated with an increased risk of persistent post-traumatic pain six months after injury. Adult patients with traumatic soft tissue injuries requiring surgical management will be enrolled and followed for six months. In addition to NPWT exposure, the study will evaluate several early clinical predictors of chronic pain, including acute pain intensity, number of surgical debridements, suspected nerve injury, and mechanism of trauma. Understanding these predictors may help clinicians identify high-risk patients early and develop targeted strategies for pain prevention and rehabilitation after severe trauma.

Participants needed: 150
Trial details
Age: 18-60Biological sex: AllType: ObservationalSponsor: Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)Updated: Mar 18, 2026Locations: 1
Eligibility criteria

age ≥18 years [+4]

chronic pain in the same anatomical region prior to injury [+4]

Status: Not yet recruiting

Tourniquet Exposure and Risk of Chronic Pain After Severe Limb Trauma

Severe limb trauma often requires the use of a tourniquet to stop life-threatening bleeding. While tourniquets are essential for saving lives, prolonged interruption of blood flow may lead to tissue ischemia, nerve injury, and inflammatory responses that could contribute to the development of chronic pain. The TOURNI-PAIN Study is a prospective observational study designed to investigate whether the duration of tourniquet use during the treatment of severe limb injuries is associated with an increased risk of persistent pain after recovery. The study will enroll adult patients with major upper or lower limb trauma who required tourniquet application in the prehospital or hospital setting. Researchers will collect information about the duration and characteristics of tourniquet use, details of the injury, surgical treatment, and recovery. Participants will be followed for up to 6 months after injury to assess pain levels, possible neuropathic pain, functional recovery, and quality of life. The goal of this research is to better understand whether longer tourniquet exposure increases the risk of long-term pain. The findings may help improve trauma care practices by balancing the life-saving benefits of hemorrhage control with strategies that minimize long-term complications and improve recovery for patients with severe limb injuries.

Participants needed: 150
Trial details
Age: 18-60Biological sex: AllType: ObservationalSponsor: Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)Updated: Mar 18, 2026Locations: 1
Eligibility criteria

Age ≥18 years [+4]

Pre-existing chronic limb pain [+3]

Status: Not yet recruiting

Venous Thromboembolism and Chronic Pain After Major Limb Trauma

Major limb trauma is associated with a high risk of venous thromboembolism (VTE) due to systemic inflammation, endothelial injury, immobilization, and hypercoagulability. While VTE is commonly studied as a short-term complication affecting morbidity and mortality, its potential relationship with long-term pain outcomes after trauma has not been well investigated. This prospective observational cohort study aims to evaluate whether objectively confirmed VTE is associated with an increased risk of persistent clinically significant pain after major limb trauma. Adult patients with severe upper or lower limb injuries requiring surgical treatment or prolonged immobilization will be enrolled within 72 hours of hospital admission and followed for six months. The study will assess whether patients who develop VTE have a higher likelihood of persistent pain compared with those without VTE. In addition, the study will explore the association between baseline VTE risk (using the Trauma Embolic Scoring System, TESS), thromboprophylaxis timing, and long-term pain outcomes. Secondary analyses will evaluate neuropathic pain symptoms, pain interference with daily activities, quality of life, opioid consumption, and functional recovery. Understanding the relationship between thromboembolic complications and persistent pain may help improve risk stratification, optimize thromboprophylaxis strategies, and support early rehabilitation planning in patients with major limb trauma.

Participants needed: 150
Trial details
Age: 18-60Biological sex: AllType: ObservationalSponsor: Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)Updated: Mar 18, 2026Locations: 1
Eligibility criteria

Age ≥18 years [+4]

Pre-existing chronic pain unrelated to trauma (investigator judgment) [+3]

Status: Not yet recruiting

From Battlefield to Recovery: Continuous Regional Anaesthesia for War-Related Lower Limb Trauma

To compare the effectiveness of continuous regional anaesthesia with standard pain management strategies for the treatment of acute pain in patients with war-related lower limb trauma.

Participants needed: 150
Trial details
Age: 18-50Biological sex: AllType: ObservationalSponsor: Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)Updated: Mar 17, 2026Locations: 1Duration: 6 Weeks
Eligibility criteria

age ≥18 years [+5]

age <18 years [+4]

Status: Not yet recruiting

Chronic Pain After Combat-Related Traumatic Brain Injury (cTBI-Pain Study) A Prospective Cohort Study of Pain Chronification After Combat-Related Traumatic Brain Injury

Combat-related traumatic brain injury (cTBI), particularly blast-related injury, is frequently associated with the development of persistent and disabling chronic pain. This prospective observational cohort study aims to determine the incidence, phenotypes, and early predictors of chronic pain following mild to moderate combat-related TBI. Adults will be enrolled within 14 days of injury and followed for 6 months. The primary endpoint is clinically significant chronic pain at 3 months, defined by pain intensity and functional interference. The study will evaluate clinical, psychological, and physiological factors to develop and internally validate a prognostic model for chronic pain risk after cTBI.

Participants needed: 100
Trial details
Age: 18-60Biological sex: AllType: ObservationalSponsor: Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)Updated: Feb 24, 2026Locations: 1Duration: 6 Months
Eligibility criteria

Age 18 to 60 years [+4]

Severe traumatic brain injury with prolonged impaired consciousness [+4]

Status: Not yet recruiting

Silencing Neuroma Pain-Botulinum Toxin Versus Local Anesthetic Injection

Neuroma-related pain is a frequent and disabling condition after limb trauma and amputation. Available treatments often provide short-lasting or insufficient analgesia. The SILENCE-NEUROMA Trial is a multicenter, randomized, double-blind, active-controlled study designed to compare the efficacy and safety of botulinum toxin type A versus local anesthetic injection for the treatment of neuroma-related pain. The primary outcome is pain reduction at 8 weeks after treatment.

Participants needed: 100
Trial details
Age: 18-50Biological sex: AllType: InterventionalSponsor: Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)Updated: Feb 25, 2026Locations: 1
Eligibility criteria

Age ≥18 years [+6]

Chronic pain condition unrelated to neuroma that predominates clinical symptoms [+6]